Company Filing History:

22 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

1 out of 1,536

Boehringer Ingelheim International Gmbh

patents

1 out of 832,843

Other

patents

Years Active: 2001-2012

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8258301 - Urotensin II receptor antagonists (2012-09-04),

2. 7465745 - Cathepsin S inhibitors (2008-12-16),

3. 7405225 - Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2008-07-29),

4. 7329764 - Substitute benzothiophene compounds (2008-02-12),

5. 7326719 - Cathepsin S inhibitors (2008-02-05),

6. 7312211 - Pryanone compounds useful as reversible inhibitors of cysteine proteases (2007-12-25),

7. 7279472 - Compounds useful as reversible inhibitors of cysteine proteases (2007-10-09),

8. 7241758 - Compounds useful as anti-inflammatory agents (2007-07-10),

9. 7056915 - Compounds useful as reversible inhibitors of cysteine proteases (2006-06-06),

10. 6982272 - Compounds useful as reversible inhibitors of cysteine proteases (2006-01-03),

11. 6974870 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-12-13),

12. 6964956 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-11-15),

13. 6936606 - Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases (2005-08-30),

14. 6858623 - Compounds useful as reversible inhibitors of cysteine proteases (2005-02-22),

15. 6841571 - Compounds useful as reversible inhibitors of cysteine proteases (2005-01-11),

Title: Sanxing Sun: Inspiring Innovation in the Heart of Danbury

Introduction:

Sanxing Sun, a visionary inventor based in Danbury, CT, is a trailblazer in the field of technology. With 24 patents to his name, his relentless pursuit of excellence continues to inspire the next generation of inventors.

Latest Patents:

One of Sanxing Sun's latest inventions includes Urotensin II receptor antagonists - compounds designed to treat cardiovascular diseases by inhibiting Urotensin II. Additionally, his work on Cathepsin S inhibitors shows promise in the treatment of autoimmune diseases.

Career Highlights:

Sanxing Sun has made significant contributions to the field while working at renowned companies like Boehringer Ingelheim Pharmaceuticals, Inc. His innovative spirit and dedication to research have led to groundbreaking advancements in the pharmaceutical industry.

Collaborations:

Throughout his career, Sanxing Sun has collaborated with esteemed professionals such as Eugene R Hickey and Weimin Liu. These partnerships have resulted in the development of cutting-edge solutions that have the potential to transform healthcare.

Conclusion:

Sanxing Sun's passion for innovation and commitment to excellence have cemented his legacy as a leading figure in the world of technology. His work not only shapes the future of the industry but also serves as a beacon of inspiration for aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com